Literature DB >> 10652254

Regulation of cell migration by amphoterin.

C Fages1, R Nolo, H J Huttunen, E Eskelinen, H Rauvala.   

Abstract

Amphoterin, a major form of HMG (high mobility group) 1 proteins, is highly expressed in immature and malignant cells. A role in cell motility is suggested by the ability of amphoterin to promote neurite extension through RAGE (receptor of advanced glycation end products), an immunoglobulin superfamily member that communicates with the GTPases Cdc42 and Rac. We show here that cell contact with the laminin matrix induces accumulation of both amphoterin mRNA and protein close to the plasma membrane, which is accompanied by extracellular export of amphoterin. A role for amphoterin in extracellular matrix-dependent cell regulation is further suggested by the finding that specific decrease of amphoterin mRNA and protein, using antisense oligonucleotides transfected into cells, inhibits cell migration to laminin in a transfilter assay whereas the oligonucleotides in the culture medium have no effect. Moreover, affinity-purified anti-amphoterin antibodies inhibit cell migration to laminin, supporting an extracellular role for the endogenous amphoterin in cell motility. The finding that amphoterin expression is more pronounced in cells with a motile phenotype as compared to cells of dense cultures, is consistent with the results of the cell migration assays. Our results strongly suggest that amphoterin is a key player in the migration of immature and transformed cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652254     DOI: 10.1242/jcs.113.4.611

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  57 in total

Review 1.  New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal.

Authors:  S Müller; P Scaffidi; B Degryse; T Bonaldi; L Ronfani; A Agresti; M Beltrame; M E Bianchi
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

2.  Extracellular processing of amphoterin generates a peptide active on erythroleukaemia cell differentiation.

Authors:  B Sparatore; M Patrone; M Passalacqua; M Pedrazzi; D Gaggero; S Pontremoli; E Melloni
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

3.  Immunological identification of endogenous peptides secreted by surviving slices of rat olfactory cortex.

Authors:  A A Mokrushin; A Plekhanov
Journal:  Dokl Biol Sci       Date:  2001 May-Jun

4.  Expression of the high-mobility group protein HMGI(Y) in human trophoblast: potential role in trophoblast invasion of maternal tissue.

Authors:  Ana-Maria Bamberger; Antonis Makrigiannakis; Kerstin Röser; Jessica Radde; Tanja Carstens; Aljoscha M Flohr; Christoph M Bamberger; Jörn Bullerdiek; Thomas Löning
Journal:  Virchows Arch       Date:  2003-09-11       Impact factor: 4.064

5.  Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages.

Authors:  Hiroki Kuniyasu; Seiji Yano; Takamitsu Sasaki; Tomonori Sasahira; Sabro Sone; Hitoshi Ohmori
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

6.  Proinflammatory Effects of Respiratory Syncytial Virus-Induced Epithelial HMGB1 on Human Innate Immune Cell Activation.

Authors:  Kempaiah Rayavara; Alexander Kurosky; Susan J Stafford; Nisha J Garg; Allan R Brasier; Roberto P Garofalo; Yashoda M Hosakote
Journal:  J Immunol       Date:  2018-10-01       Impact factor: 5.422

7.  HMGB1 recruits hepatic stellate cells and liver endothelial cells to sites of ethanol-induced parenchymal cell injury.

Authors:  Yeon S Seo; Jung H Kwon; Usman Yaqoob; Liu Yang; Thiago M De Assuncao; Douglas A Simonetto; Vikas K Verma; Vijay H Shah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-03       Impact factor: 4.052

Review 8.  High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

Authors:  Shu Zhu; Wei Li; Mary F Ward; Andrew E Sama; Haichao Wang
Journal:  Inflamm Allergy Drug Targets       Date:  2010-03

Review 9.  High-mobility group box 1 (HMGB1) in childhood: from bench to bedside.

Authors:  Valeria Chirico; Antonio Lacquaniti; Vincenzo Salpietro; Caterina Munafò; Maria Pia Calabrò; Michele Buemi; Teresa Arrigo; Carmelo Salpietro
Journal:  Eur J Pediatr       Date:  2014-05-09       Impact factor: 3.183

10.  Antibodies against hepatoma-derived growth factor and mucosal repair in ulcerative colitis.

Authors:  Hideji Nakamura; Kenya Yoshida; Kazuhiro Ikegame; Yoshihiko Kishima; Hirokazu Uyama; Hirayuki Enomoto
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.